Concepedia
Statistics
Publications
128
Citations
9.9K
H-Index
52
Active since
1993
Affiliations
Innsbruck Medical University(Current)
Universität Innsbruck
Landeskrankenhaus Feldkirch
Medical University of Vienna
Johannes Gutenberg University Mainz
Zoran Čulig is an author at Innsbruck Medical University specializing in oncology, prostate cancer, and life sciences.
Publications per year
1993–2024
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Zoran Čulig, Alfred Hobisch, Marcus V. Cronauer et al. · PubMed · 1994 · 943 citations
Life Sciences, Endocrinology, Molecular Biology +17
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
Alfred Hobisch, Iris E. Eder, Thomas Pütz et al. · PubMed · 1998 · 439 citations
Life Sciences, Endocrinology, Oncology +13
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Zoran Čulig, Jens Hoffmann, Martin Erdel et al. · British Journal of Cancer · 1999 · 421 citations · Full text
Medicine, Oncology, Pharmacology +17
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Zoran Čulig, Alfred Hobisch, Marcus V. Cronauer et al. · Molecular Endocrinology · 1993 · 417 citations · Full text
Medicine, Endocrinology, Molecular Biology +17
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
Martin Puhr, Julia Hoefer, Georg Schäfer et al. · American Journal Of Pathology · 2012 · 261 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 128